Estimating New Viral Hepatitis Infections From Reported Acute Cases in the United States
Open Forum Infectious Diseases · 31.10.2026 · 13 (11)
DOI: 10.1093/ofid/ofag669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 15.10.2026. Verfasst von Joshua A Salomon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy, Stanford University School of Medicine, Stanford, California, USA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
New viral hepatitis infections may go unreported because many infections are asymptomatic, some people with symptoms do not seek testing, and gaps in surveillance capacity limit identification of acute cases. We present an updated approach to estimate the burden of new viral hepatitis infections from reported acute cases.
Methods
We estimated the proportion of new viral hepatitis infections expected to be symptomatic from the literature and the proportion of symptomatic patients expected to seek testing from a national survey. We estimated reporting proportions for new hepatitis A virus (HAV) and hepatitis B virus (HBV) infections from the literature and developed a Poisson regression model to estimate the proportion of new hepatitis C virus (HCV) infections reported as acute cases based on predictors of jurisdictional surveillance capacity.
Results
Overall multipliers to adjust reported acute cases in 2022 ranged from 1.6 (95% uncertainty interval [95% UI] 1.4–2.1) to 2.6 (2.0–3.6) across jurisdictions for hepatitis A, 5.7 (3.1–21.7) to 9.1 (4.7–35.1) for acute hepatitis B, and 2.8 (2.1–3.9) to 67.3 (33.8–140.8) for acute hepatitis C. Applying these multipliers, estimated numbers of new HAV, HBV, and HCV infections in 2022 nationally were 4732 (95% UI 4344–5387), 15 725 (13 515–35 455), and 39 734 (31 212–57 515), respectively.
Conclusions
Reported cases might substantially underestimate new viral hepatitis infections, and adjustment factors vary widely by jurisdiction. Our updated approach enables public health officials to estimate the burden of new viral hepatitis infections more accurately for program planning and evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Policy, Stanford University School of Medicine, Stanford, California, USA.
- Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Joshua A Salomon, Shannon M Casillas, Nicola D Thompson, Jonathan Tang, Lijia Zheng
Förderung
- Centers for Disease Control and Prevention
Zitieren
APA
Salomon, J. A., Hoots, B., Casillas, S. M., Thompson, N. D., Tang, J., Zheng, L., & Gupta, N. (2026). Estimating New Viral Hepatitis Infections From Reported Acute Cases in the United States. Open Forum Infectious Diseases, 13(11). https://doi.org/10.1093/ofid/ofag669
Vancouver
Salomon JA, Hoots B, Casillas SM, Thompson ND, Tang J, Zheng L, et al. Estimating New Viral Hepatitis Infections From Reported Acute Cases in the United States. Open Forum Infectious Diseases. 2026;13(11). doi:10.1093/ofid/ofag669
BibTeX
@article{Salomon2026,
author = {Salomon, Joshua A and Hoots, Brooke and Casillas, Shannon M and Thompson, Nicola D and Tang, Jonathan and Zheng, Lijia and Gupta, Neil},
title = {Estimating New Viral Hepatitis Infections From Reported Acute Cases in the United States},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {11},
doi = {10.1093/ofid/ofag669}
}
EUVIMED